Novel combination for treating sexual dysfunction
AssigneeBayer Aktiengesellschaft
InventorsErwin Bischoff, Hilmar Bischoff, Francois Giuliano
Life of this patent
Estimating the term…
Abstract
Disclosed is a combination preparation for the treatment of sexual dysfunction in men or women containing at least one active ingredient A and one active ingredient B as pharmaceutically active ingredients, whereby the active ingredient A is a PDE inhibitor, preferably a cGMP PDE inhibitor and the active ingredient B a lipid-reducing agent. Both the active ingredients A and B can be administered simultaneously or at alternate intervals, that is, as a functional unit or separated from each other.
Claims21
A combination preparation, comprising as pharmaceutically active ingredients at least one active compound component A and at least one active compound component B, characterized in that the active compound component A is a PDE inhibitor, preferably a cGMP PDE inhibitor, and the active compound component B is an antilipemic.
The combination preparation as claimed in any of claims I to 6, characterized in that the antilipemic (active compound component B) is selected from the group consisting of (a) HMG-CoA-reductase inhibitors;
- (b) squalene synthase inhibitors;
- (c) bile acid sequestrants;
- (d) fibric acid and its derivatives;
- (e) nicotinic acid and its analogs;
- (f) ω3-fatty acids.
The use of antilipemics for enhancing the activity of PDE inhibitors, in particular cGMP PDE inhibitors.
Dependencies are inferred from the claim text.